Crossmark

Management of extravasation of oxaliplatin by mimicking its biotransformation

Crossref DOI link: https://doi.org/10.1007/s12094-018-1854-z

Published Online: 2018-04-27

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bahadori, F.

Demiray, M. https://orcid.org/0000-0003-2501-3097
License Information

Text and Data Mining valid from 2018-04-27
More Information

Article History

Received: 29 December 2017

Accepted: 23 February 2018

First Online: 27 April 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All the principles outlined in the Helsinki Declaration of 1975, as revised in 2008 (5), have been followed in all the experiments involving human subjects during the current study. This case report does not contain any identifiable information about the patient.

: Informed consent was obtained.